Measuring the Value of New Medications and Implications for Medicare’s Proposed Part B Drug Payment Model
| Autor: | John L. LaMattina, Thomas J Hwang |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Drug
Cancer Research Value-Based Purchasing media_common.quotation_subject Antineoplastic Agents Drug Costs Reimbursement Mechanisms 03 medical and health sciences 0302 clinical medicine New medications Neoplasms Humans Medicine 030212 general & internal medicine Medicare Part B Health policy media_common Actuarial science business.industry Payment reform Health Policy Reimbursement Mechanism medicine.disease Payment United States Pharmaceutical Preparations Oncology 030220 oncology & carcinogenesis Medical emergency Health Expenditures business |
| Zdroj: | JAMA Oncology. 2:1125 |
| ISSN: | 2374-2437 |
| DOI: | 10.1001/jamaoncol.2016.2037 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|